COMP <GO>
MYGN vs TKNO // PIOTROSKI F-SCORE QUALITY
Myriad Genetics Inc. (NASDAQ) VS. Alpha Teknova Inc. (NASDAQ) • 15-METRIC TALLY: MYGN 5
— TKNO 5
▲ PIOTROSKI F-SCORE QUALITY LEADER: MYGN
LAST: $6.67 (+0.60%) • MKT CAP: $638.0M
piotroski-score
6/9
LAST: $8.09 (+2.93%) • MKT CAP: $499.2M
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MYGN VS. TKNO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MYGN | TKNO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.90% | 33.20% | +36.70 | MYGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -21.30% | -13.70 | TKNO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.28% | -1.96% | +2.24 | MYGN | /fcf-yield <GO> |
| Operating Margin | -47.00% | -41.90% | -5.10 | TKNO | /operating-margins <GO> |
| Net Profit Margin | -44.40% | -42.60% | -1.80 | TKNO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.60% | 7.40% | -9.00 | TKNO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 6.93 | -6.73 | TKNO | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 5/9 | +1.00 | MYGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.7 | 48.1 | +24.55 | MYGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $638.0M | $499.2M | $138.8M | MYGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MYGN REV | TKNO REV | MYGN GROSS % | TKNO GROSS % | MYGN FCF | TKNO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $824.5M | $40.5M | 69.9% | 33.2% | $1.8M | -$9.8M |
| FY 2024 | $837.6M | $37.7M | 69.9% | 19.2% | -$8.7M | -$13.5M |
| FY 2023 | $753.2M | $36.7M | — | — | -$110.9M | -$18.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MYGN // BETA —
TKNO // BETA —